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Synthesis of pharmaceutical drugs from cardanol
derived from cashew nut shell liquid†‡
Yiping Shi, Paul C. J. Kamer § and David J. Cole-Hamilton *
Cardanol from cashew nut shell liquid extracted from cashew nut shells was successfully converted into
various useful pharmaceutical drugs, such as norfenefrine, rac-phenylephrine, etilefrine and fenoprofene.
3-Vinylphenol, the key intermediate for the synthesis of these drugs, was synthesised from cardanol by
ethenolysis to 3-non-8-enylphenol followed by isomerising ethenolysis. The metathesis reaction worked
very well using DCM, but the greener solvent, 2-methyl tetrahydrofuran, also gave very similar results.
Hydroxyamination of 3-vinylphenol with an iron porphyrin catalyst aﬀorded norfenefrine in over 70%
yield. Methylation and ethylation of norfenefrine aﬀorded rac-phenylephrine and etilefrine respectively. A
sequence of C–O coupling, isomerising metathesis and selective methoxycarbonylation aﬀorded feno-
profene in good yield. A comparison of the routes described in this paper with some standard literature
syntheses of 3-vinylphenol and of the drug molecules shows signiﬁcant environmental advantages in
terms of precursors, yields, number of steps, conditions and the use of catalysts. The Atom Economy of
our processes is generally similar or signiﬁcantly superior to those of the literature processes mainly
because the side products produced during synthesis of 3-vinylphenol (1-octeme, 1,4-cyclohexadiene
and propene) are easily separable and of commercial value, especially as they are bio-derived. The
E Factor for the production of 2-vinylphenol by our process is also very low compared with those of pre-
viously reported syntheses.
Introduction
Cashew nut shell liquid (CNSL) is a natural oil and a byproduct
of cashew nut manufacture. Around 30–35% of the shell
weight is CNSL,1 and about ∼1 M tonnes of CNSL is produced
annually worldwide.2 Presently, in the cashew nut industry,
cashew nut shells are disposed of as furnace materials, and
are burnt in a semi-open pit for thermal energy generation for
roasting the nuts. They are also burnt for cooking applications,
which is a quick and cheap way for disposal. However, these
applications have very low combustion eﬃciency.3
CNSL contains a mixture of products including anacardic
acid, 1, cardanol, 2, cardol, 3, and 2-methylcardol, 4, which
contain diﬀerent functional groups, the aromatic ring, the
hydroxyl group, the carboxylic acid and the double bonds in
the alkyl chain (Fig. 1). For this reason, cashew nut shell liquid
has versatile applications, and it can be used for a wide range
of chemical modifications to produce useful monomer precur-
sors. CNSL derived material can be used as chemical inter-
mediates, additives,4,5 stabilizers,6 lubricants,7 diesel engine
fuel alternatives,8 anti-oxidants,9 anticorrosive paints, sodium
cardanol sulfate detergent,10 coating, brake linings11 and
resins.12 Although there is a large number of applications of
cashew nut shell liquid (CNSL) and its components, anacardic
acid and cardanol, there are very few examples of the trans-
formation of cashew nut shell liquid and its components into
small value-added molecules. The examples predominantly
focused on the metathesis of the double bonds in anacardic
Fig. 1 Components of CNSL.
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acid and cardanols using either homogeneous or hetero-
geneous catalysis (the latter with Ru catalysts supported on
mesoporous molecular sieve SBA-15).13
Metathesis reactions of anacardic acid and cardanol for the
synthesis of fine chemicals and new hybrid functional
materials have been reviewed.14 Cardanol porphyrins, cardanol
phthalocyanines and cardanol fullerenes can all be produced
by metathesis of cardanol derivatives.14 These interesting
studies enabled the synthesis of challenging molecules.
However, it would be more interesting to synthesise products
with practical use. It has previously been reported in our group
that the tsetse fly attractants, 3-ethyl phenol and 3-propyl
phenol can both be produced selectively in good yields (>80%)
from cardanol.15
We have also used homogeneous metathesis,16–18 isomeris-
ing metathesis,15 methoxycarbonylation18 and isomerisa-
tion17,19 to make higher added value chemicals such as
3-nonylphenol,16,17 1-octene,16,17 1,3-cyclohexadiene,16,17
which allows ethenolysis using simple first generation meta-
thesis catalysts,16,20 potential monomers containing hydroxy
and carboxyl groups,18 fused bicyclic compounds19 and large
ring macrocyles.18 To the best of our knowledge, the only
report of converting CNSL, anacardic acid or cardanol into
pharmaceutical drugs is the synthesis of ginkgolic acid, a tyro-
sinase inhibitor, from anacardic acid, which appeared while
this manuscript was under review.21 although we have reported
the synthesis of a substituted isochromen-1-one which has
some structural similarities to massoia lactone from anarcar-
dic acid.19 Pharmaceutical drugs are mainly synthesised from
fossil fuels by stoichiometric reactions, and in some cases
toxic reagents such as cyanide are involved, which renders the
synthesis environmentally unfriendly. Our target was to syn-
thesise pharmaceutical drugs from renewable feedstocks
which do not compete with food. An inedible by-product from
food processing, in this case cashew nut shell liquid, is there-
fore a very good starting material. The aromatic and olefin
functional groups make cardanol suitable for this purpose.
After searching through the drug database, five drugs (feno-
profen, 5, norfenefrine, 6, phenylephrine, 7, etilefrine, 8, and
metaraminol, 9) were found to be of potential interest. The
importance and the current synthesis of these drugs will be
discussed in detail later. Their general structures, containing a
meta-hydroxyl group, are similar to the ones in cardanol, 2, or
anacardic acid, 1, from CNSL (highlighted in red, Scheme 1).
Only a few steps of modification are needed to convert food by-
products into high value and important medicines, which will
be discussed in detail later.
Results and discussion
The initial retrosyntheses of the target drugs are summarised
in Scheme 1, from which it can be concluded that 3-vinyl-
phenol, 10, is the key intermediate for the synthesis of the rele-
vant drugs. Therefore, the initial study was focused on convert-
ing CNSL and derivates (e.g. anacardic acid and cardanol) into
3-vinylphenol, 10.
3-vinylphenol
3-Vinylphenol, 10, could be obtained by an ethenolysis of
cardanol acid to give 3-(non-8-enyl)phenol, 11, as the intermedi-
ate, which was followed by a one-pot isomerising ethenolysis.15
Following a similar reaction procedure previously reported in
our group,15 3-(non-8-enyl)phenol, 11, was obtained in 96%
yield after ethenolysis of cardanol with HG1 catalyst, 12
(Table 1, entry 1). The yield was slightly lower with G1 catalyst,
Scheme 1 Retrosynthesis of target drugs, with the relationship to cardanol, 2.
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13 (85%, Table 1, entry 2), and only 11% yield of 3-(non-8-enyl)
phenol, 11, was obtained when cardanol was metathesized
with HG2 catalyst, 14 (Table 1, entry 3). Very similar results
were obtained when the greener solvent, 2-methyl THF, was
used (Table 1, entry 4). However, when anacardic acid, 1, was
used as substrate, very poor conversions were observed using
either HG1, 12, or HG2 catalysts, 14 (Table 1, entries 5 and 6).
Reproduction of the isomerizing metathesis of 11 was carried
out using ruthenium (M1, 15) and palladium dimer, 16,
the desired 3-vinylphenol, 10, was obtained in 78% yield
(Scheme 2), which is consistent with the literature results.15
The synthesis of 3-vinylphenol, 10, could also, in principle,
be carried out by a two-step synthesis: isomerisation of carda-
nol to the benzylic cardanol followed by ethenolysis. Previous
studies in our group showed that the [Pd2(dba)3]/DTBPMB/
MSA system, which is active for the isomerising methoxycarbo-
nylation of methyl oleate,22 and is a good isomerisation cata-
lyst in the absence of CO, is eﬀective for isomerising cardanol,
although the yield of benzylic alkene was only 40%. This is the
thermodynamic maximum. Although the styrene will be the
most thermodynamically favoured isomer, the conjugation
energy is insuﬃcient to overcome the entropic advantage of
having the double bond in other positions in the chain com-
pletely. Therefore, the cardanol was shortened by ethenolysis
to produce 3-(non-8-enyl)phenol, 11, with the method pre-
viously mentioned (96% yield, Table 1, entry 1). 3-(Non-8-enyl)
phenol, 11, was isomerized with [Pd2(dba)3]/DTBPMB/MSA in
toluene at 80 °C, after 64 hours, the benzylic product, 3-(non-
1-en-1-yl)phenol, 17, was obtained in 68% selectivity over all
the other isomers (Table 2, entry 1). Heating at 80 °C for
96 hours led to 71% selectivity of 17 (Table 2, entry 2).
Isomerisation of 3-(non-8-enyl)phenol with Pd catalyst can also
be carried out in other solvents. Very similar results were
obtained in DCM, THF or in a greener solvent, 2-MeTHF
(Table 2, entries 3–8). [Rh(acac)(CO)2] together with DTBPMB
ligand is known to be eﬀective in isomerising hydroformyla-
tion of cardanol,23 therefore, it was interesting to find out
whether [Rh(acac)(CO)2]/DTBPMB is eﬀective in the isomeriza-
tion reaction in the absence of CO/H2 gas. However, no
benzylic alkene was observed after 64 hours, and only 28% of
the terminal alkene was converted to other internal alkenes
(Table 2, entry 9).
After isomerization of 3-(non-8-enyl)phenol, 11, the meta-
thesis reaction was then carried out on the crude product from
the isomerisation step (71% of 17, Table 2, entry 2). The crude
product was metathesized using M1 catalyst, 15, and 3-vinyl-
phenol, 10, was obtained in 65% yield by GC-FID together with
alkenyl phenols with longer chain lengths (Scheme 3).
Table 1 Metathesis of anacardic acid and cardanol to 3-(non-8-enyl)
phenola
Entry Substrate Catalyst Yield (%)
1 Cardanol HG1 96
2 Cardanol G1 85
3 Cardanol HG2 11
4b Cardanol HG1 93
5 Anacardic acid HG2 <1
6 Anacardic acid HG1 1
a Reagents and conditions: Substrate (3 mmol), catalyst (0.3 mol%),
anhydrous DCM (7.5 mL), ethene (10 bar), 24 h, r.t. b 2-Methyl THF
(7.5 mL) instead of DCM.
Scheme 2 Synthesis of 3-vinyl phenol by isomerising metathesis using
a palladium dimer (isomerisation) and M1 (metathesis) catalyst.
Table 2 Optimisation of alkene isomerisationa
Entry Cat prec. solvent
T
(°C)
t
(h)
Sel. (benzylic alkene/
others)b (%)
1 [Pd2(dba)3] Toluene 80 64 68
2 [Pd2(dba)3] Toluene 80 96 71
3 [Pd2(dba)3] DCM 40 64 68
4 [Pd2(dba)3] DCM 40 96 70
5 [Pd2(dba)3] THF 70 64 62
6 [Pd2(dba)3] THF 70 96 62
7 [Pd2(dba)3] 2-MeTHF 80 64 63
8 [Pd2(dba)3] 2-MeTHF 80 96 63
9 [Rh(acac)(CO)2] Toluene 80 64 0
a Reagents and conditions: Substrate (50 mg, 0.2 mmol, 1 equiv.), cata-
lyst (5 mol%) DTBPMB (0.5 equiv.), MSA (0.7 equiv.), solvent (1 mL).
b Selectivity calculated by quantitative 1H NMR.
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Synthesis of norfenefrine
Norfenefrine, 6, is an adrenergic agent used as a sympathomi-
metic drug, which is pharmaceutically active in its racemic
form. Norfenefrine, 6, plays a role as a minor neurotransmitter
in the brain and regulates blood pressure in acute hypotensive
states.25
As presented in Scheme 1, 3-vinylphenol, 10, which was
successfully obtained from cardanol by ethenolysis followed by
isomerising metathesis, could possibly be used as an inter-
mediate for the synthesis of norfenefrine, 6, by a hydroxyami-
nation reaction on the double bond. Morandi reported a reac-
tion of this kind which converts 1-methoxy-3-vinylbenzene, 18,
to 2-amino-1-(3-methoxyphenyl)ethan-1-ol, 19, in 70% yield
using an iron catalyst and O-pivaloylhydroxylammonium tri-
flate (Scheme 4, Reaction A).24 We employed a similar method
using 3-vinylphenol, 10, as substrate, and the desired norfene-
frine, 6, which is also known as 3-(2-amino-1-hydroxyethyl)
phenol, was obtained in 71% isolated yield (Scheme 4,
Reaction B).
Synthesis of metaraminol
Metaraminol, 9, which is used in the prevention and treatment
of hypotension,26 has a very similar structure as norfenefrine,
6. It is active in its enantiopure form. It is interesting to inves-
tigate if the hydroxyamination reaction used for the synthesis
of norfenefrine, 6, would work when using 3-(prop-1-en-1-yl)
phenol, 20, as substrate. According to literature data, hydroxy-
amination of styrene, 21, occurs in 74% yield, while using
β-methyl styrene, 22, as substrate gave around 20% yield
(Scheme 5, Reaction A).24 The extra methyl group on the side
chain led to a dramatic decrease of the yield. A reaction using
the same hydroxyamination conditions as for 3-vinylphenol
was carried out on 3-(prop-1-en-1-yl)phenol, 20. The desired
racemic metaraminol, 9, was obtained in 24% NMR yield in
this case (Scheme 4, Reaction B). This is in line with the
results from the literature.
Synthesis of racemic phenylephrine
Phenylephrine which has a similar structure to that of norfe-
nefrine, is a sympathomimetic, vasoconstrictor, mydriatic and
cardiotonic agent. It can be used as decongestant, pupil
dilator, vasopressor and in the treatment of hemorrhoids and
priapism, to dilate the pupil or to increase the blood pressure,
Scheme 3 Synthesis of 3-vinylphenol in two steps from 3-non-8-enyl
phenol.
Scheme 4 Hydroxyamination of styrene type substrate. (A) Literature
hydroxyamination of 1-methoxy-3-vinylbenzene, 18.24 (B) Experimental
synthesis of norfenefrine, 6, from 3-vinylphenol, 10.
Scheme 5 Synthesis of metaraminol, 9, and related literature results.24
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it is active as the L-isomer.25 Selective methylation of norfenefr-
ine, 6, could result in the formation of racemic phenylephrine,
7. However, there are three active sites for the direct alkylation,
both of the hydroxy groups and the amine groups are readily
available for the reaction.
When reacting norfenefrine, 6, with methyl iodide in the
presence of a base, a rather complicated mixture of products
was obtained, which might be because of methylation on
alcohol, mono- and dimethylated products, and selective
methylation was not achieved by this method (Table 3, entries
1 and 2). It has been reported that 1,1,1,3,3,3-hexafluoro-2-
propanol (HFIP) is a good solvent for the selective alkylation of
amines, producing a high proportion of mono-alkylated pro-
ducts over di-alkylated products.22 Methylation of norfenefrine
with methyl iodide in HFIP in the absence of base gave very
poor conversion, and low yield of the desired phenylephrine
(Table 3, entry 3). By changing the methylation agent from
methyl iodide to methyl triflate, much higher conversion was
observed, and the desired phenylephrine, 7, was obtained in
79% yield (Table 3, entry 4).
Synthesis of etilefrine
Another drug with a similar structure to that of norfenefrine,
6, is etilefrine, 8, which is a cardiac stimulant, and is used as
an antihypotensive. Etilefrine is pharmaceutically active in its
racemic form. Etilefrine can increase cardiac output, stroke
volume, venous return and blood pressure by intravenous infu-
sion.27 It is also an analeptic and sympathomimetic agent.25
Reductive amination was used for the selective alkylation of
nitrogen over the oxygen. When reacting norfenefrine, 6, with
acetaldehyde in the presence of sodium borohydride, both the
desired etilefrine, 8, and the side diethylated product 23 were
obtained, and they were easily separated by flash column
chromatography. The expected etilefrine, 8, was obtained in
54% yield, and the diethylated product was obtained in 35%
yield (Scheme 6).
Due to the success of the methylation procedure for the
selective mono-methylation of norfenefrine, we employed
these conditions in the synthesis of etilefrine using ethyl tri-
flate as the ethyl source. The ethylation of norfenefrine with
ethyl triflate in HFIP led to a higher yield of the desired etilefr-
ine (79%) compared to the reductive amination, together with
17% of the diethylated product after 1 hour at room tempera-
ture (Scheme 7).
Synthesis of fenoprofen
Another drug, which contains a meta-hydroxy phenyl group
similar to CNSL, is fenoprofen, 5, which is a nonsteroidal anti-
inflammatory drug (NSAID) and is marketed in the USA as
Nalfon, which is also pharmaceutically active in its racemic
form. The current cost for its oral capsules (400 mg) is around
$256 for a supply of 90 capsules.28 It is eﬀective for the treat-
ment of fever, pain and swelling caused by inflammation.
A few synthetic pathways have been tested (ESI, section
S1‡). The best reaction pathway is to convert cardanol to the
O-Ph cardanol, 24, firstly, which could avoid the complexity of
the C–O coupling with unstable intermediates (e.g. styrene
intermediate 10 in Scheme S1‡).
Cardanol, 3, was therefore reacted with bromobenzene first
in the presence of anhydrous potassium tert-butoxide under
literature conditions for the C–O coupling of the phenol
(Step A, Scheme 8).29 Only about 30% of cardanol was con-
verted to the O-Ph product, 24, at 45 °C. Increasing the tem-
perature increased the conversion, and at 100 °C, the starting
material was fully converted. Preparative scale gave similar
results, and the O-Ph cardanol, 24, was successfully syn-
thesised in 82% yield.
After obtaining O-Ph cardanol, 24, 1-phenoxy-3-vinyl-
benzene, 25, can be synthesized in two steps (Step B and C in
Scheme 8). Firstly, the O-Ph cardanol, 24, was metathesized to
the corresponding 1-(non-8-en-1-yl)-3-phenoxybenzene, 26,
using HG1 catalyst in high yield (97%) with 1-octene as the
side product. 1-(Non-8-en-1-yl)-3-phenoxybenzene, 26, was
then converted to 1-phenoxy-3-vinylbenzene, 25, by the isomer-
Scheme 6 Synthesis of etilefrine, 8 from norfenefrine, 6.
Scheme 7 Ethylation of norfenefrine using ethyl triﬂate.
Table 3 Methylation of norfenefrinea
Entry MX Solvent T (°C) t (h) Conv.b (%) Yieldb (%)
1c MeI Acetone 60 2 100 n.d.
2c MeI DMSO 100 16 100 n.d
3 MeI HFIP 25 24 4 2
4 MeOTf HFIP 25 1 84 79
a Conditions: Norfenefrine (1 mmol), MeX (1.5 mmol), HFIP (1 mL).
b Conversions and yields were calculated by 1H NMR spectroscopy.
c KOH (2 equiv.).
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ising metathesis reaction with palladium dimer and M1 cataly-
sis, as discussed earlier for the synthesis of 3-vinylphenol. A
one-pot isomerising metathesis of 1-(non-8-en-1-yl)-3-phenoxy-
benzene, 26, first aﬀorded a mixture of 1-phenoxy-3-vinyl-
benzene, 25, and 1-phenoxy-3-(prop-1-en-1-yl)benzene, 27. The
crude mixture was filtered through a plug of silica, and
metathesized again with M1 catalyst. The desired 1-phenoxy-3-
vinylbenzene, 25, was successfully obtained in 80% yield
(Scheme 9).
The next step is the synthesis of the branched ester 28 (Step
D, Scheme 8). Branch selective methoxycarbonylation with Pd/
DTBPMB system in the presence of racemic BINOL-phosphoric
acid (rac-BNPA) aﬀorded the desired product 28 in 82% yield
together with 12% of the linear product, methyl 3-(3-phenoxy-
phenyl)propanoate, 29 (Scheme 10). Hydrolysis of 28 in 1,4-
dioxane aﬀorded fenoprofen, 5, in 91% yield. The hydrolysis of
28 can also be carried out in DMSO, which aﬀord the desired
fenoprofen, 5, in 92% yield. However, the hydrolysis reaction
in 2-MeTHF did not give the desired product at all. With this
method, biomass is successfully converted to fenoprofen drug
in good yield (47.5% overall yield from cardanol, 2).
Enantioselective synthesis of the branched ester 28, from
1-phenoxy-3-vinylbenzene, 25, was also performed using a cata-
lyst developed by Clarke,30 30 (Scheme 11). After 17 h, 44%
Scheme 8 The synthesis of fenoprofen.
Scheme 9 Synthesis of 1-phenoxy-3-vinylbenzene by isomerising metathesis.
Scheme 10 Synthesis of fenoprofen from 1-phenoxy-3-vinylbenzene.
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conversion was observed, with 69% branched to linear selecti-
vity and 88% ee.
Comparisons with literature processes
3-Vinylphenol. We have reported the synthesis of four
important drug molecules from cardanol, a readily available
byproduct of food manufacture, in this case cashew nuts. In
most cases yields are high and only a few steps are involved.
Although making drugs from renewable resources which do
not compete for land with food is attractive in its own right, it
is also important to compare our syntheses with others based
on fossil fuel or other bioderived feedstocks.
The main platform chemical for this study is 3-vinylphenyl,
which we have synthesised from cardanol in 75% isolated
yield after two steps. 3-Vinylphenol has been made in one step
by pyrolysis of cardanol31,32 or from fossil fuel derived cyclo-
hexanone.33 We note that the first step of our synthesis, ethe-
nolysis of cardanol produces products as shown in Fig. 2.
It is clear from analysis of Table 4 that our route is superior
to pyrolysis because of the low temperatures used, the high
yield and the side products. 1-Octene (from ethenolysis of car-
danol containing 1 double bond is a valuable chemical used
as a co-monomer for polyethylene and is required on 500 000
tonne per year in the US alone at a value of $1–2000 per
tonne.34,35 1,4-Cyclohexadiene (self-metathesis of cardanol
containing 3 double bonds; note that this does not require
ethene) is a useful organic synthon and hydrogen donor or
acceptor36 and we have shown that it can allow ethenolysis of a
number of alkenes including methyl oleate to proceed cleanly
using cheap first-generation ruthenium-based metathesis cata-
lysts.16,37 Indeed, it is essential for the clean ethenoylsis of car-
danol in the first step of the synthesis of 3-vinylphenol dis-
cussed here. Both 1-octene and cyclohexanone can be separ-
ated easily from one another and from 3-(non-8-enyl)phenol by
distillation. The second step of the synthesis of 3-vinylphenol
produces propene (>94%)15 as the by-product. This is also a
valuable commodity chemical (∼100 000 tonnes per year) used
for making polymers and plasticisers and in the cumarin
process for the manufacture of phenol.38 The price of
propene39 is similar to that of ethene40 per mol, so making it
as a side product in this way is an attractive proposition.
As the demand for bio derived polymers rises, bio-1-octene
and bio-propene will also be essential. The first step of our
process produces 1-octene with 87.5% of the C derived from
bioresources. If the ethenolysis were carried out using bio-
ethene, from bioethanol, the 1-ocetene would be 100% bio-
derived. Similarly, if bio-ethene were used for the isomerising
metathesis, 100% bio-propene would be the by-product.
On the basis of atom economy, the synthesis of 3-vinyl-
phenol from 3-vinylcyclohex-2-enone33 looks attractive. However,
the oxidant is dimethylsulphoxide, which gives no useful side
Scheme 11 Enantioselective methoxycarbonylation of 1-phenoxy-3-
vinylbenzene. Reagents: 1-Phenoxy-3-vinylbenzene (0.55 mmol), LiCl
(2 mol%), para-toluenesulfonic acid monohydrate (2 equiv.), 30 (1 mol%),
MeOH (0.75 mL), CO (30 bar), 40 °C, 17 h.30
Fig. 2 Products from the ethenolysis of each component of cardanol. The percentage ﬁgures on the right refer to the amount of each component
in the batch used in this study.
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products and the yield is only 45%. For a direct comparison,
we need to look at the synthesis from basic building blocks.
3-Vinylcyclohex-2-enone is derived from benzene, a non renew-
able resource in six steps via cumarin, cumarin peroxide,
phenol, cyclohexan-2-one (Birch reduction) and finally 3-vinyl
cyclohex-2-enone.41 Many of these steps are atom ineﬃcient
and or involve stoichiometric metal reagents.
Thus, on the basis of simplicity, mild conditions (important
because 3-vinylphenol is unstable), yield, renewable resources
that are of low value and not used in food and the value of the
side products, the synthesis of 3-vinylphenol from cardanol
seems to be very much more attractive than other available
syntheses.
Norfenefrine. Norfenefrine can be synthesised in 5 steps
from benzene (Scheme 12). Acetophenone synthesised from
the benzene by a Friedel–Crafts reaction,46 was reacted with
bromine fluoride to form the 1-(3-bromophenyl)ethan-1-one.47
The bromide was converted to 1-(3-hydroxyphenyl)ethan-1-one
by using a Pd/tBuPhos system.48 2-Bromo-1-(3-bromophenyl)
ethan-1-one was then formed by using Montmorillonite K10,
aluminium chloride and bromine.49 And finally, hexamethyl-
enetetramine was used to convert 2-bromo-1-(3-bromophenyl)
ethan-1-one to the desired norfenefrine.50 The atom eﬃciency
is 24%. The total atom eﬃciency of our process is 36% when
taking into account useable side products, which is higher
than that for the published reaction. In addition, fewer steps
are required, fossil fuel resources are not used and it only
consist of three steps, all catalytic from cardanol.
Phenylephrine. Phenylephrine is industrially synthesised
from benzaldehyde in 8 steps. Benzaldehyde can be extracted
from bitter almond oil. Nitration of benzaldehyde with oxalyl
chloride, dimethyl formamide and KNO3 aﬀords 3-nitrobenz-
aldehyde,51 which can then be hydrogenated to 3-aminobenz-
aldehyde with molecular hydrogen and palladium on Fe(OH)x
solid support.52 3-Aminobenzaldehyde is converted to
3-hydroxybenzaldehyde with sodium nitrite and sulfuric
acid.53 3-Hydroxybenzaldehyde was protected by methoxy-
ethoxymethyl chloride and diisopropyl ethyl amine. The methoxy-
ethoxymethyl ether was treated with dimethyloxosulfonium
methylide, which generated the racemic epoxide. Kinetic
resolution by hydrolysis with (R,R)-N,N′-bis(3,5-di-tert-butyl-
salicylidene)-1,2-cyclohexanediaminocobalt acetate complex
provided the (S)-diol along with the unreacted (R)-epoxide,
which were then separated by column chromatography.
Opening of the desired (R)-epoxide with methanolic methyl-
amine gave amino alcohol. Finally, removal of the methox-
yethoxymethyl group by refluxing in methanolic HCl aﬀorded
the desired compound as the HCl salt (Scheme 13).54 The syn-
thesis of phenylephrine has an atom economy of 39% to the
hydrochloride. Using NaOH to give the free phenylephrine
would reduce the atom economy to 30%. Our method starting
from cashew nut shell liquid has an atom economy of 22%
when taking useful products into account, but it does not
involve protection and deprotection.
Etilefrine. The synthesis of etilefrine can be achieved start-
ing from benzene, 1-(3-hydroxyphenyl)ethan-1-one is obtained
using the same initial pathway to the synthesis of
norfenefrine.46–48 1-(3-Hydroxyphenyl)ethan-1-one was then
converted to 3-acetylphenyl acetate using magnesium perchlor-
ate as catalyst,55 and a bromination of 3-acetylphenyl acetate
aﬀorded 3-(2-bromoacetyl)phenyl acetate,56 which was then
converted to the etilefrine with ethylamine, sodium boro-
hydride and water (Scheme 14).57 The atom eﬃciency of this
Table 4 Comparisons with literature process for the synthesis of 3-vinylphenol
Metathesis of cardanol Pyrolysis of cardanol31,32 From 3-vinylcyclohex-2-enone33
Number of steps 2 1 1
Step 1 Step 2 6 from benzene
Other reagents C2H4 C2H4 None DMSO
Temperature /°C 25 40–80 540–600 100
Isolated yield/% 96 70 12–15 45% (final step)
Side products 1-Octene, 1,4-cyclohexadiene Propene 3-Ethylphenol, 3-methylphenol,
phenol, alkenes and alkanes
(C2–4 and higher), high boiling
residue
Unknown
Small amount of volatile
hydrocarbons from cardanol
with 2 double bonds.
Atom economy42,43 65 47
Overall atom economy 31 40 59.4
Atom economy (all usable products) 92 100
Over all atom economy (all usable
products
92 40 59.4
E Factor44,45/kg (waste) kg (products)−1 0.09 0.1 76
Scheme 12 Synthesis of the norfenefrine in literature.
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fossil fuel based synthetic method is 28%, which is slightly
higher than our synthetic method starting from cashew nut
shell liquid, 22%.
Fenoprofen. Fenoprofen is traditionally synthesised from
3-hydroxyacetophenone by stoichiometric reactions in 5 steps
including the use of sodium cyanide and phosphorus tribro-
mide (Scheme 15).58 3-Hydroxyacetophenone, is C–O coupled
by bromobenzene using potassium carbonate and copper cata-
lyst to 3-phenoxyacetophenone. The ketone is reduced using
sodium borohydride to the corresponding alcohol, which is
then brominated to 1-(1-bromoethyl)-3-phenoxybenzene, by
phosphorous tribromide. The bromide is converted to a nitrile
group using sodium cyanide. Finally, 2-(3-phenoxyphenyl)pro-
pionitrile, is hydrolyzed to the desired fenoprofen.58 This well-
known reaction pathway requires environmentally unfriendly
stoichiometric conditions in most of the steps. It also involves
sodium cyanide, which is dangerous to handle. Our method
omitted the unpleasant cyanide step and converted bio-
derived cardanol into fenoprofen. The atom eﬃciency of our
method (taking usable side products into account) is 68%
which is higher than the atom eﬃciency of the reported
method (30%) shown in Scheme 15. In addition, although
3-hydroxyacetophenone can be bio-derived as a component of
castoreum, the exudate from the castor sacs of the mature
beaver, it seems unlikely that this could be a commercially
viable source, so further steps may be required for the pro-
duction of fenoprofen by this route.
Although we have demonstrated significant advantages of
the routes to certain pharmaceuticals described in this paper
over conventional synthetic processes, we acknowledge that
the synthesis of drugs and their precursors is tightly controlled
by the United Nations Convention59 against illicit drugs and
psychotropic substances, 1988 and EU60 legislation and that
the high purity required of the final products is also enforced
under the International Convention on Harmonisation (ICH)
Guidelines.61 Further work on the process engineering by qua-
lified API or drug manufacturers will be required before these
routes from cardanol can be fully implemented.
Scheme 13 Original synthesis of phenylephrine.
Scheme 14 The original synthesis of etilefrine.
Scheme 15 Original synthesis of fenoprofen.
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Conclusions
Relatively inexpensive cardanol, an inedible component
cashew nut shell liquid has been successfully converted to
important and high-value medicinal drugs, such as norfenefr-
ine, phenylephrine, etilefrine and fenoprofen in good yields by
mostly catalytic reactions. For fenoprofen, the key methoxy-
carbonylation step has been demonstrated with good enantio-
selectivity. The greener solvent, 2-methyl THF, gave very good
results for the metathesis of cardanol. Our methods start from
a readily available and relatively cheap bio-based resource, gen-
erally use catalytic reactions, have fewer steps and avoid
unpleasant reagents. They have atom eﬃciencies better than
or similar to those of literature syntheses. An added attraction
of these synthetic procedures is that the valuable commodity
chemicals, 1-octene (from monounsaturated cardanol) and
1,4-cyclohexadiene (from triunsaturated cardanol) are signifi-
cant products of the first ethenolysis reaction and propene is
the side product of the isomerising metathesis step. These
valuable side products make the E factor for synthesis of
3-vinylphenol by our route very low compared with those of
previously reported syntheses.
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